Library
BCM-95® (CURCUGREEN®), 20 Mar 2015
Published on : Eur Neuropsychopharmacol . 2015 Jan;25(1):38-50. doi: 10.1016/j.euroneuro.2014.11.015. Epub 2014 Dec 5.
Adrian L Lopresti 1, Michael Maes 2, Marc J M Meddens 3, Garth L Maker 4, Eddy Arnoldussen 3, Peter D Drummond 5
PMID: 25523883 DOI: 10.1016/j.euroneuro.2014.11.015
Curcumin and major depression: A randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change
Adrian L. Loprestia, Michael Maesb, Marc J.M. Meddensd, Garth L. Makere, Eddy Arnoldussend, Peter D. Drummonda
doi.10.1016|j.2014.11.015
Abstract: A recent randomised, double-blind, placebo controlled study conducted by our research group, provided partial support for the efficacy of supplementation with a patented curcumin extract (500 mg, twice daily) for 8 weeks in reducing depressive symptoms in people with major depressive disorder.
Procedure: Participants were randomly and equally allocated into two groups (placebo and curcumin) using a randomisation calculator. Both curcumin and placebo capsules were packed in identical containers labelled by participant code numbers and allocation was assigned by the first author according to order of participant enrolment in the study. As no previous clinical study has investigated the effect of curcumin on most of the measured biomarkers, data to complete an a priori power analysis could not be determined. However, to achieve a power of 0.8, sample size estimates were based on the assumption of a moderate effect size of 0.4 indicating a total sample size of approximately 50 was required for this study.
Results: Univariate tests exploring the effects of the group by time on the different individual urinary biomarkers revealed significant group time interactions.
Conclusion: Important preliminary findings were identified as Urinary cortisol levels trended downward following placebo treatment and trended upward following curcumin treatment, resulting in significant between-group differences. Determining reasons for these differences are difficult as they were not related to treatment outcome. Speculatively, curcumin may have enhanced endothelin or leptin receptor sensitivity or some other mechanism associated with biomarkers which, in turn, had antidepressant effects.
Limitations: The relatively small samples size and the large number of statistical analyses used in this study limits the reliability and statistical power associated with the findings.
Pathogenic involvement of neuropeptides in anxiety and depression. Alldredge B Neuropeptides, (3):215-224 2010 MED: 20096456
Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Belcaro G, Cesarone MR, Dugall M, Pellegrini L, Ledda A, Grossi MG, Togni S, Appendino G Altern Med Rev, (4):337-344 2010 MED: 21194249
HPA axis and aging in depression: systematic review and meta-analysis Belvederi Psychoneuroendocrinology 2014
Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical study. Bergman J, Miodownik C, Bersudsky Y, Sokolik S, Lerner PP, Kreinin A, Polakiewicz J, Lerner V Clin Neuropharmacol, (3):73-77 2013 MED: 23673908
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Biomarkers Definitions Working Group. Clin Pharmacol Ther, (3):89-95 2001 MED: 11240971
Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response. Blier P, Gobbi G, Haddjeri N, Santarelli L, Mathew G, Hen R J Psychiatry Neurosci, (3):208-218 2004 MED: 15173897
Depression predicts elevated endothelin-1 in patients with coronary artery disease. Burg MM, Martens EJ, Collins D, Soufer R Psychosom Med, (1):2-6 2010 MED: 20947777
Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. Chuengsamarn S, Rattanamongkolgul S, Phonrat B, Tungtrongchitr R, Jirawatnotai S J Nutr Biochem, (2):144-150 2013 MED: 24445038
The role of substance P in stress and anxiety responses. Ebner K, Singewald N Amino Acids, (3):251-272 2006 MED: 16820980
Differential effects of curcumin on vasoactive factors in the diabetic rat heart. Farhangkhoee H, Khan ZA, Chen S, Chakrabarti S Nutr Metab (Lond), 27 2006 MED: 16848894
Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment. Galecki P, Szemraj J, Bienkiewicz M, Florkowski A, Galecka E Pharmacol Rep, (3):436-447 2009 MED: 19605942
Cytokine modulation by endothelin-1 and possible therapeutic implications in systemic sclerosis. Giordano N, Papakostas P, Pecetti G, Nuti R J Biol Regul Homeost Agents, (4):487-492 2011 MED: 22217982
Subchronic treatment with aldosterone induces depression-like behaviours and gene expression changes relevant to major depressive disorder. Hlavacova N, Wes PD, Ondrejcakova M, Flynn ME, Poundstone PK, Babic S, Murck H, Jezova D Int J Neuropsychopharmacol, (2):247-265 2011 MED: 21375792
Endothelin concentrations in cerebrospinal fluid in depressive patients Hoffman Lancet, (8678–8679) 1989
Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Holmes A, Heilig M, Rupniak NM, Steckler T, Griebel G Trends Pharmacol Sci, (11):580-588 2003 MED: 14607081
Blunted aldosterone and ACTH release after human CRH administration in depressed patients. Holsboer F, Gerken A, Stalla GK, Muller OA Am J Psychiatry, (2):229-231 1987 MED: 3028185
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Howren MB, Lamkin DM, Suls J Psychosom Med, (2):171-186 2009 MED: 19188531
Attenuation of endothelin-1-induced PKB and ERK1/2 signaling, as well as Egr-1 expression, by curcumin in A-10 vascular smooth muscle cells. Kapakos G, Youreva V, Srivastava AK Can J Physiol Pharmacol, (9):1277-1285 2012 MED: 22913328
Endothelin--biology and disease. Khimji AK, Rockey DC Cell Signal, (11):1615-1625 2010 MED: 20466059
Comparison of the effects of endothelin-1 and -3 on secretion of pituitary hormones in healthy male volunteers. Kiefer F, Kellner M, Jahn H, Wiedemann K Exp Clin Endocrinol Diabetes, (5):378-381 2000 MED: 10989958
Low doses of curcumin protect alcohol-induced liver damage by modulation of the alcohol metabolic pathway, CYP2E1 and AMPK Lee Life Sci., (18–19) 2013
Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Leonard B, Maes M Neurosci Biobehav Rev, (2):764-785 2011 MED: 22197082
Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects. Lopresti AL, Hood SD, Drummond PD J Psychopharmacol, (12):1512-1524 2012 MED: 23035031
Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. Lopresti AL, Maes M, Maker GL, Hood SD, Drummond PD J Affect Disord, 368-375 2014 MED: 25046624
A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers. Lopresti AL, Maker GL, Hood SD, Drummond PD Prog Neuropsychopharmacol Biol Psychiatry, 102-111 2013 MED: 24104186
The leptin hypothesis of depression: a potential link between mood disorders and obesity? Lu XY Curr Opin Pharmacol, (6):648-652 2007 MED: 18032111
The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression Maes Neuroendocrinology Lett., (1) 2008
In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes. Maes M, Kubera M, Leunis JC, Berk M, Geffard M, Bosmans E Acta Psychiatr Scand, (5):344-354 2012 MED: 22900942
Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis/chronic fatigue syndrome Maes Neuroendocrinol. Lett., (6) 2009
The DEX/CRH test for major depression: a potentially useful diagnostic test. Mokhtari M, Arfken C, Boutros N Psychiatry Res, (2):131-139 2013 MED: 23291044
Molecular and anatomical determinants of central leptin resistance. Munzberg H, Myers MG Jr Nat Neurosci, (5):566-570 2005 MED: 15856064
Role of brain thromboxane A2 in the release of noradrenaline and adrenaline from adrenal medulla in rats. Okada S, Murakami Y, Yokotani K Eur J Pharmacol, (1-3):125-131 2003 MED: 12706465
Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial. Panahi Y, Saadat A, Beiraghdar F, Sahebkar A Phytother Res, (10):1461-1467 2014 MED: 24648302
Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial. Panahi Y, Sahebkar A, Amiri M, Davoudi SM, Beiraghdar F, Hoseininejad SL, Kolivand M Br J Nutr, (7):1272-1279 2011 MED: 22099425
High plasma concentrations of cortisol and thromboxane B2 in patients with depression. Piccirillo G, Fimognari FL, Infantino V, Monteleone G, Fimognari GB, Falletti D, Marigliano V Am J Med Sci, (3):228-232 1994 MED: 8160715
Role of endothelin-1 receptor blockers on hemodynamic parameters and oxidative stress. Piechota A, Polanczyk A, Goraca A Pharmacol Rep, (1):28-34 2010 MED: 20360613
Bosentan, a mixed endothelin receptor antagonist, induces antidepressant-like activity in mice. Pinho-Ribeiro FA, Borghi SM, Staurengo-Ferrari L, Filgueiras GB, Estanislau C, Verri WA Jr Neurosci Lett, 57-61 2013 MED: 24361136
The Inventory of Depressive Symptomatology (IDS): psychometric properties. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH Psychol Med, (3):477-486 1996 MED: 8733206
Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Sanmukhani J, Satodia V, Trivedi J, Patel T, Tiwari D, Panchal B, Goel A, Tripathi CB Phytother Res, (4):579-585 2013 MED: 23832433
Pharmacology and physiopathology of the brain endothelin system: an overview. Schinelli S Curr Med Chem, (6):627-638 2006 MED: 16529555
Sympathy for the devil: the role of thromboxane in the regulation of vascular tone and blood pressure. Sellers MM, Stallone JN Am J Physiol Heart Circ Physiol, (5):H1978-86 2008 MED: 18310512
Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Serebruany VL, Glassman AH, Malinin AI, Nemeroff CB, Musselman DL, van Zyl LT, Finkel MS, Krishnan KR, Gaffney M, Harrison W, Califf RM, O'Connor CM; Sertraline AntiDepressant Heart Attack Randomized Trial Study Group Circulation, (8):939-944 2003 MED: 12912814
Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Shah BH, Nawaz Z, Pertani SA, Roomi A, Mahmood H, Saeed SA, Gilani AH Biochem Pharmacol, (7):1167-1172 1999 MED: 10484074
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 Sheehan J. Clin. Psychiatry, (Suppl. 20):S22- 1998
Endothelin and dopamine release. van den Buuse M, Webber KM Prog Neurobiol, (4):385-405 2000 MED: 10670706
Lifetime history of depression, type 2 diabetes, and endothelial reactivity to acute stress in postmenopausal women. Wagner JA, Tennen H, Finan PH, White WB, Burg MM, Ghuman N Int J Behav Med, (4):503-511 2012 MED: 21964983
The role of nuclear factor-kappa B in bacterial translocation in cholestatic rats. Weber-Mzell D, Zaupa P, Petnehazy T, Kobayashi H, Schimpl G, Feierl G, Kotanko P, Hollwarth M Pediatr Surg Int, (1):43-49 2006 MED: 16333628
[Effects of qingyi II granules on intestinal bacterial translocation in rats with acute necrotizing pancreatitis]. Xiao QC, Dui DH, Lan TG Zhongguo Zhong Xi Yi Jie He Za Zhi, (10):905-909 2009 MED: 20073222
Leptin signaling and leptin resistance. Zhou Y, Rui L Front Med, (2):207-222 2013 MED: 23580174
Leptin as a neuroactive agent. Zupancic ML, Mahajan A Psychosom Med, (5):407-414 2011 MED: 21597032
Let’s collaborate to refine your ideas or built from scratch
Arjuna Natural is India’s leading manufacturer and exporter of standardized botanical extracts for pharmaceutical and nutraceutical industries for more than two decades. Established in 1989, the company has grown...Read More